I immensely enjoy helping companies and institutions translate ground-breaking scientific innovations into strong, creative and dynamic intellectual property assets to gain a competitive edge, maximize revenue and meet long-term business objectives.
mpavao@cooley.com
Dr. Matthew Pavao advises public and private companies, including early stage companies, as well as research and educational institutions, on all aspects of intellectual property to maximize revenue and meet their business objectives.
Download full bio
Reata Pharmaceuticals – $505 Million Follow-On Offering
ERYTECH – $144 Million IPO
Selecta Biosciences – $74 Million IPO
Inotek Pharmaceuticals – $50 Million Follow-On
Voyager Therapeutics - $80.5 Million IPO
Intellectual Property
Patent Counseling & Prosecution – Life Sciences
Patent Office Litigation
Life Sciences
Medtech
Family
Traveling
Beer Brewing
Scuba Diving
Matthew provides helpful, well thought-out counsel. He is extremely practical and very creative.
Suffolk UniversityJD, magna cum laude, 2006
Boston University PhD, Biochemistry2001
Boston University MA, Medical Sciences1995
University of MassachusettsBS, Biology, Zoologycum laude, 1993
Massachusetts
United States Patent & Trademark Office
Chambers USA 2021 Recognizes Cooley Lawyers + Practices May 28, 2021
Cooley Advises on Follow-On Offerings for Reata + argenx December 5, 2019
Best Lawyers 2020 – Cooley November 18, 2019
View all
Boston Patent Law Association
American Intellectual Property Law Association
Chambers: Leading Patent Lawyer
Super Lawyers: Leading IP Lawyer
+1 617 937 2340
Locations